7-Chloro-1,2,3,4-tetrahydro-1- (2-methyl-4-nitrobenzoyl) -5H-1-benzazepin-5-ib CAS 137982-91-3

Khoom Piav Qhia:

Khoom Lub Npe: 7-Chloro-1,2,3,4-tetrahydro-1- (2-methyl-4-nitrobenzoyl) -5H-1-benzazepin-5-ib CAS TSIS: 137982-91-3

Lub ntsiab lus:

7-chloro-1- (2-methyl-4-nitrobenzoyl) -5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine;

7-Chloro-1- (2-methyl-4-nitrobenzoyl) -3,4-dihydro-1H-benzo [b] azepin-5 (2H) -one;

1H-benzo [b] azepine;

Tshuaj& Lub Cev Muaj Zog:

Tsos: Dawb rau dawb-dawb khoom

Kev Ntsuas: ≥99.00%

Ceev: 1.387

Kub Point: 573.345 ℃ ntawm 760 mmHg

Flash Point: 300.548 ℃

Vapor Siab: 0.0 ± 1.6 mmHg ntawm 25 ℃

Index ntawm Refraction: 1.635

Cia: Cov tub yees, nyob hauv qhov chaw tsis huv

Solubility: DMSO (Me ntsis), Methanol (Me ntsis)

Cov Ntaub Ntawv Kev Nyab Xeeb:

HS Code: 2933990090

7-Chloro-1,2,3,4-tetrahydro-1- (2-methyl-4-nitrobenzoyl) -5H-1-benzazepin-5-ib yog qhov nruab nrab hauv kev sib xyaw Tolvaptan-d7 (T536652), daim ntawv lo Tolvaptan (T536650). Nws yog qhov kev xaiv, sib tw arginine vasopressin V2 receptor antagonist siv los kho hyponatremia (qib ntshav qis sodium) cuam tshuam nrog kev mob plawv tsis ua haujlwm, mob ntshav qab zib, thiab cov tsos mob ntawm cov tshuaj tsis haum tshuaj tiv thaiv kab mob (SIADH).

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: 7-chloro-1,2,3,4-tetrahydro-1- (2-methyl-4-nitrobenzoyl) -5h-1-benzazepin-5-one cas 137982-91-3, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: 1- (4-Amino-2-methylbenzoyl) -7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ib CAS 137977-97-0
• Tom ntej: 7-CHLORO-1,2,3,4-TETRAHYDRO-BENZO [B] AZEPIN-5-ONE CAS 160129-45-3